Oramed Pharmaceuticals Share Price (NASDAQ: ORMP)
$2.19
Last updated on
Check the interactive Oramed Pharmaceuticals Stock chart to analyse performance
Oramed Pharmaceuticals stock performance
as on August 30, 2025 at 1:27 am IST
- Today's Low:$2.18Today's High:$2.21
0.46%
Downside
Day's Volatility :1.36%
Upside
0.9%
- 52 Weeks Low:$1.8252 Weeks High:$3.09
16.89%
Downside
52 Weeks Volatility :41.1%
Upside
29.13%
Oramed Pharmaceuticals Stock Returns
Oramed Pharmaceuticals Inc Key Stats
Check Oramed Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Oramed Pharmaceuticals Stock including INR - Dollar returns
The Oramed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Oramed Pharmaceuticals investment value today
Current value as on today
₹96,155
Returns
Returns from Oramed Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Oramed Pharmaceuticals Stock
Global Institutional Holdings in Oramed Pharmaceuticals Inc
Name
Holdings %
BML Capital Management LLC
7.55%
Murchinson Ltd.
4.29%
BOOTHBAY FUND MANAGEMENT, LLC
2.07%
Rathbone Brothers PLC
0.57%
Dimensional Fund Advisors, Inc.
0.41%
Bank of America Corp
0.40%
Analyst Recommendation on Oramed Pharmaceuticals Stock
Hold
0%Buy
57%Hold
42%Sell
Based on 7 Wall street analysts offering stock ratings for Oramed Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Oramed Pharmaceuticals Share Price Target
What analysts predicted
Upside of 48.4%
Target:
$3.25
Current:
$2.19
Oramed Pharmaceuticals share price target is $3.25, a slight Upside of 48.4% compared to current price of $2.19 as per analysts' prediction.
Oramed Pharmaceuticals Stock Insights
Price Movement
In the last 3 years, ORMP stock has moved down by -74.1%Increasing Revenue
Revenue is up for the last 4 quarters, 666.0K → 2.0M (in $), with an average increase of 22.5% per quarterIncreasing Net Profit
Netprofit is up for the last 4 quarters, -19.61M → 13.28M (in $), with an average increase of 94.5% per quarterORMP vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 78.3%ORMP vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 186.7%Price to Sales
ForORMP every $1 of sales, investors are willing to pay $44.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Oramed Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Oramed Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Oramed Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 3.3% | 9.5% | -9.13% | -73.61% | -81.23% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 4.55 | NA | 0.0 | -0.34 | -0.15 | -0.05 | NA | 3.78 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Hold | $90.2M | -81.23% | 4.55 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Oramed Pharmaceuticals Inc
Key Management of Oramed Pharmaceuticals Inc
Important FAQs about investing in ORMP Stock from India :
What is Oramed Pharmaceuticals share price today?
Oramed Pharmaceuticals share price today is $2.19 as on at the close of the market. Oramed Pharmaceuticals share today touched a day high of $2.21 and a low of $2.18.
What is the 52 week high and 52 week low for Oramed Pharmaceuticals share?
Oramed Pharmaceuticals share touched a 52 week high of $3.09 and a 52 week low of $1.82. Oramed Pharmaceuticals stock price today i.e. is closed at $2.19, lower by 29.13% versus the 52 week high.
How to invest in Oramed Pharmaceuticals Stock (ORMP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Oramed Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oramed Pharmaceuticals Shares that will get you 0.6849 shares as per Oramed Pharmaceuticals share price of $2.19 per share as on August 30, 2025 at 1:27 am IST.
What is the minimum amount required to buy Oramed Pharmaceuticals Stock (ORMP) from India?
Indian investors can start investing in Oramed Pharmaceuticals (ORMP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Oramed Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Oramed Pharmaceuticals share’s latest price of $2.19 as on August 30, 2025 at 1:27 am IST, you will get 4.5662 shares of Oramed Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Oramed Pharmaceuticals has given to Indian investors in the last 5 years?
Oramed Pharmaceuticals stock has given -81.23% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%